UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$495M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Global Payments
GPN
|
+$400M |
| 4 |
Mastercard
MA
|
+$274M |
| 5 |
Comcast
CMCSA
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$225M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$190M |
| 3 |
Apple
AAPL
|
+$167M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$166M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Wyndham Hotels & Resorts
WH
$5.48B
| $8.08M | 0.01% |
156,245
+6,237
| +4% | +$341K |
|
|
BHVN
1002
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $8.08M | 0.01% |
193,758
+14,942
| +8% | +$631K |
|
|
ZNGA
1003
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $8.05M | 0.01% |
1,383,903
+339,160
| +32% | +$2.04M |
|
1004
Five Below
FIVE
$13.5B
| $8.03M | 0.01% |
63,706
+8,784
| +16% | +$1.07M |
|
1005
Diamondrock Hospitality Co
DRH
$2.56B
| $8.03M | 0.01% |
783,214
+98,444
| +14% | +$971K |
|
1006
Globus Medical
GMED
$11.2B
| $8.02M | 0.01% |
156,898
+10,138
| +7% | +$483K |
|
|
BOLD
1007
DELISTED
Audentes Therapeutics, Inc
BOLD
| $8.02M | 0.01% |
285,467
+5,953
| +2% | +$203K |
|
1008
Quanta Services
PWR
$101B
| $8M | 0.01% |
211,679
-6,131
| -3% | -$221K |
|
1009
Exponent
EXPO
$3.24B
| $7.9M | 0.01% |
113,026
+6,676
| +6% | +$451K |
|
|
CEO
1010
DELISTED
CNOOC Limited
CEO
| $7.85M | 0.01% |
51,579
+14
| +0% | +$2.2K |
|
1011
Sonos
SONO
$1.85B
| $7.81M | 0.01% |
582,756
+6,836
| +1% | +$85.5K |
|
1012
ITT
ITT
$19.1B
| $7.81M | 0.01% |
127,582
+304
| +0.2% | +$18.3K |
|
1013
SAP
SAP
$238B
| $7.79M | 0.01% |
66,116
-5,096
| -7% | -$631K |
|
|
JP
1014
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
| $7.78M | 0.01% |
3,323,505
| – | – |
|
|
DCPH
1015
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.7M | 0.01% |
+226,999
| New | +$6.72M |
|
1016
Spotify
SPOT
$100B
| $7.69M | 0.01% |
67,471
+2,441
| +4% | +$345K |
|
|
XHR
1017
Xenia Hotels & Resorts
XHR
$1.79B
| $7.66M | 0.01% |
362,631
+35,588
| +11% | +$746K |
|
|
CLR
1018
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $7.65M | 0.01% |
248,594
-616
| -0.2% | -$20.8K |
|
1019
Tenable Holdings
TENB
$4.01B
| $7.64M | 0.01% |
341,329
+5,161
| +2% | +$131K |
|
1020
Moderna
MRNA
$23.6B
| $7.62M | 0.01% |
+478,343
| New | +$7.07M |
|
|
SGMO
1021
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $7.59M | 0.01% |
838,854
+39,399
| +5% | +$442K |
|
1022
PG&E
PCG
$38.5B
| $7.54M | 0.01% |
754,398
-4,681
| -0.6% | -$70.8K |
|
1023
Cable One
CABO
$212M
| $7.52M | 0.01% |
5,996
+207
| +4% | +$257K |
|
|
MDSO
1024
DELISTED
Medidata Solutions, Inc.
MDSO
| $7.46M | 0.01% |
81,482
+14,432
| +22% | +$1.32M |
|
1025
iQIYI
IQ
$1.28B
| $7.44M | 0.01% |
461,063
+78,015
| +20% | +$1.43M |
|
Similar funds
UBS AM's Q3 2019 Portfolio in Review
As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $167M trimmed.
- UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
- UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
- UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
- UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
- UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
- UBS AM opened 79 new positions and closed 50 in Q3 2019.
- UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.
Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.